Spotlight & News
Biosense Webster Receives FDA Approval for THERMOCOOL SMARTTOUCH® SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation
READ MORE
First Patients in Europe Treated with Biosense Webster VARIPULSE® Catheter for Atrial Fibrillation Treatment
READ MORE
Atrial Fibrillation: A Brief Guide to Patient Impact, Disease Management and Treatment Outcomes
READ MORE
Biosense Webster Launches CARTO® 3 System Version 7 and the CARTO PRIME® Mapping Module to Advance Treatment of Complex Arrhythmias
READ MORE
Biosense Webster Receives CE Mark Approval for QDOT MICRO®, The World's First Very High Power, Short Duration Ablation Catheter
READ MORE
BIOSENSE WEBSTER UNVEILS LATE-BREAKING RESULTS FROM PRECEPT STUDY IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
READ MORE
VISTAX Study Results Show High Rate of 12-Month Freedom from Arrhythmia
READ MORE
HONORING THE EXTRAORDINARY LIFE OF A MEDICAL DEVICE INVENTOR
READ MORE
INTELLIGENT DATA ANALYTICS SOFTWARE SOLUTION COMES TO ELECTROPHYSIOLOGY WITH LAUNCH OF BIOSENSE WEBSTER’S CARTONET
READ MORE
BIOSENSE WEBSTER ANNOUNCES INITIAL RESULTS FROM FIRST IN-HUMAN STUDY OF NOVEL HIGH POWER-SHORT DURATION ABLATION CATHETER FOR ATRIAL FIBRILLATION
READ MORE
FIRST PATIENT TREATED IN BIOSENSE WEBSTER U.S. IDE STUDY EVALUATING NEXT GENERATION BALLOON ABLATION CATHETER FOR ATRIAL FIBRILLATION
READ MORE
PATIENT ENROLLMENT COMPLETED IN U.S. IDE STUDY OF THERMOCOOL SMARTTOUCH® SF CATHETER FOR TREATMENT OF PERSISTENT ATRIAL FIBRILLATION
READ MORE
BIOSENSE WEBSTER, INC. ANNOUNCES FIRST PATIENT TREATED IN STUDY OF MULTI-ELECTRODE RADIOFREQUENCY BALLOON CATHETER
READ MORE